Close
Nordic 9Nordic 9

SV Health Investors (investor - Private Equity)

United Kingdom svhealthinvestors.com
See something wrong or missing? Let us know
Offices:London
Average round investment:55.51M USD
Average number per year:3.3
Distribution: 2025 (6)2024 (2)2023 (3)2022 (3)2021 (5) See the entire list
Portfolio companies: United Kingdom Artios PharmaUnited Kingdom AlchemabUnited Kingdom NRG Therapeutics See the entire list
Mostly invests in: United Kingdom United Kingdom (18) Health services (20)
See the entire list

Showing 3 of 20 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

SV Health Investors mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to SV Health Investors

Name Criteria
Italy Panakès Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Ireland
  • Average number of deals per year: 3.2
  • Active last 12 months: Yes
United States Promus Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.2
  • Active last 12 months: Yes
United States Battery Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.6
  • Active last 12 months: Yes
United Kingdom Cambridge Innovation Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Ireland
  • Average number of deals per year: 3.7
  • Active last 12 months: Yes
France Jeito Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.7
  • Active last 12 months: Yes
United States Uncorrelated Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
Germany Bosch Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Ireland Seroba Life Sciences
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Ireland
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
United States Invus
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Israel 83North
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Ireland
  • Average number of deals per year: 4.9
  • Active last 12 months: Yes
Top